However, with respect to WISCI, constipation, headache, and urinary tract infection, there was no significant difference in the efficacy and safety of placebo, pregabalin, GM-1 ganglioside, venlafaxine XR, fampridine, conventional OT, BWSTT, RAGT + OT, and BWSOT on patients with SCI (Fig. S2–3 and Tables 4 and 5). The gene discussed is PPP1R3A; the disease is urinary tract infection.